Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Title
Intervention Indication Therapeutic Area Year Actions
Crizanlizumab (formerly SelG1) for Sickle Cell Disease Crizanlizumab (SEG101; Adakveo) Sickle cell anaemia Haematology 2017 View  |  Download
Clostridium botulinum Type A toxin (Dysport) for Spasmodic torticollis Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Spasmodic torticollis Musculoskeletal System , Neurology 2017 View  |  Download
Clostridium botulinum neurotoxin A (Xeomin) for lower limb spasticity due to cerebral palsy – first line Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Lower limb spasticity Musculoskeletal System , Neurology 2017 View  |  Download
Cethrin for traumatic spinal cord injury Cethrin (BA 210; VX-210) Spinal cord injury Musculoskeletal System 2017 View  |  Download
Certolizumab pegol (Cimzia) for chronic plaque psoriasis in adults Certolizumab (CDP-870; Cimzia; certolizumab pegol) Plaque psoriasis Dermatology 2017 View  |  Download
Cenicriviroc for non-alcoholic steatohepatitis (NASH) Cenicriviroc (TAK-652; Cenicriviroc Mesylate) Non-alcoholic steatohepatitis (NASH) Hepatology 2017 View  |  Download
Cemiplimab for advanced cutaneous squamous cell Cemiplimab (Libtayo; REGN2810) Squamous cell carcinoma (SCC) Skin Cancer 2017 View  |  Download
Cannabidiol in a pharmaceutical formulation (Epidiolex; GWP42003-P) for Lennox-Gastaut syndrome in children and adults Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS) Lennox-Gastaut syndrome Neurology 2017 View  |  Download
Cannabidiol (Epidiolex) for Tuberous Sclerosis Complex - add-on therapy Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS) Tuberous sclerosis Genetic Disorders 2017 View  |  Download
Canakinumab (ILARIS) for Cardiovascular risk reduction – Add on therapy Canakinumab (Ilaris; ACZ885) Cardiovascular disease (CVD) Cardiovascular System 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications